www.kcameetings.org Open in urlscan Pro
2606:4700:3032::6815:2c39  Public Scan

Form analysis
1 forms found in the DOM

GET https://www.kcameetings.org/

<form id="gecko-search-form" class="nav-search" method="get" action="https://www.kcameetings.org/">
  <input class="form-control required" name="s" placeholder="Search...">
  <button class="search-icon"><span class="pe-7s-search"></span></button>
</form>

Text Content

 * Contact
 * Newsletter Signup
 * Donate

 * About
 * IKCS: North America
 * IKCS: Europe
 * Past Events
 * Contact

 * 


 * About
 * IKCS: North America
 * IKCS: Europe
 * Past Events
 * Contact


2022 IKCS: NORTH AMERICA PROGRAM AGENDA

Explore the Program by Day

Thursday, November 3, 2022

SessionsTimeSpeakerRegistration Open1:30 PM- 7:00 PMKCA Think Tank Meeting (by
Invitation Only)2:00 PM- 5:00 PMWelcome and First Time Attendee Happy Hour
(In-person Only)
Marker 10, Hyatt Regency Austin Lobby bar5:00 PM- 6:00 PMA First-line Treatment
Option for Your Adult Patients With Advanced Renal Cell Carcinoma
Supported by Eisai
Hill Country Ballroom6:00 PM- 7:00 PMSandy Liu, MD
City of Hope Orange County RCC Clinical Consults: Making Difficult Treatment
Decisions at the Intersection of the Data and the Real World (CME offered by
PeerView Oncology)
Supported by PeerView Oncology
Hill Country Ballroom7:00 PM- 8:00 PM

Friday, November 4, 2022

SessionsTimeSpeakerRegistration Open6:30 AM- 6:00 PMPoster and Exhibit Hall
Open6:30 AM– 6:30 PMWomen in RCC Networking (In-person with Virtual Zoom Option)
Big Bend Ballroom A/B6:45 AM- 7:45 AMMaria Carlo, MD
Memorial Sloan Kettering Cancer CenterBreak7:45 AM- 8:00 AMWelcome to 2022 IKCS:
North America
Zilker 3-48:00 AM- 8:10 AMEric A. Singer, MD, MA, MS, FACS, FASCO
Ohio State Wexner Medical Center

Tian Zhang, MD, MHS
University of Texas Southwestern Medical CenterWelcome and Session 1: Treatment
Debates
Zilker 3-48:10 AM- 10:00 AMVitaly Margulis, MD
University of Texas Southwestern Medical Center

Rana McKay, MD
University of California, San DiegoDebate 1: Surveillance vs Intervention8:10
AM- 8:45 AMPhillip M. Pierorazio, MD
Penn Presbyterian Medical Center, Penn Medicine

Raquib Hannan, MD, PhD
University of Texas Southwestern Medical CenterDebate 2: Adjuvant or Not?8:45
AM- 9:20 AMBradley McGregor, MD
Dana-Farber Cancer Institute

Naomi Haas, MD
Penn MedicineDebate 3: Doublet or Triplet as first-line Treatment in Kidney
Cancer9:20 AM- 10:00 AMYousef Zakharia, MD
University of Iowa

Rana McKay, MD
University of California, San DiegoSession 2: Side-effect Management and Quality
of Life Perspectives in Kidney Cancer Treatment
Zilker 3-410:00 AM- 11:00 AMKiran Virdee, RN CCRN-K
Memorial Sloan Kettering Cancer CenterDisease and Symptom Management, Supportive
Care Options, and Understanding Patient-reported Outcomes10:00 AM- 10:20
AMElizabeth Wulff-Burchfield, MD
University of Kansas Medical CenterThe Patient Perspective on Side-effects and
Care10:20 AM- 10:25 AMLaura Esfeller Daily Aspects of Side-effect Management
Logistics10:25 AM- 10:35 AMKiran Virdee, RN CCRN-K
Memorial Sloan Kettering Cancer CenterMultidisciplinary Panel Discussion and
Q+A: Navigating Renal Cell Carcinoma Side-effects Beyond Urology and
Oncology10:35 AM- 11:00 AMKiran Virdee, RN CCRN-K
Memorial Sloan Kettering Cancer Center

Elizabeth Wulff-Burchfield, MD
University of Kansas Medical Center

Yan Liu, MD, PhD
Ascension Texas Cardiovascular

Afreen Shariff, MD, MBBS
Duke Health

Michael Dougan, MD, PhD
Massachusetts General HospitalBreak11:00 AM- 11:30 AMSession 3: The Professional
State of RCC
Zilker 3-411:30 AM- 11:50 AMW. Kimryn Rathmell, MD, PhD
Vanderbilt University Medical CenterThe Professional State of RCC11:30 AM- 11:50
AMSession 4: Professional Development Workshop (In-person Only)11:50 AM- 1:00
PMEric A. Singer, MD, MA, MS, FACS, FASCO
Ohio State Wexner Medical Center

Tian Zhang, MD, MHS
University of Texas Southwestern Medical CenterIntroduction11:50 AM- 11:55
AMEric A. Singer, MD, MA, MS, FACS, FASCO
Ohio State Wexner Medical Center

Tian Zhang, MD, MHS
University of Texas Southwestern Medical CenterBreakout Group 1: Professional
Development and What I Wish I’d Known 10 Years Earlier11:55 AM- 12:30 PMBradley
C. Leibovich, MD
Mayo Clinic

Tian Zhang, MD, MHS
University of Texas Southwestern Medical Center

Daniel J. George, MD
Duke UniversityBreakout Group 2: Learning from Others’ Experience- How and When
to Consider Career Moves11:55 AM- 12:30 PMBrian Rini, MD
Vanderbilt University Medical Center

Eric A. Singer, MD, MA, MS, FACS, FASCO
Ohio State Wexner Medical Center

Jodi Maranchie, MD
University of Pittsburgh Medical Center

W. Kimryn Rathmell, MD, PhD
Vanderbilt University Medical CenterBreakout Group 3: Career Opportunities in
Industry and Options Outside of Academia11:55 AM- 12:30 PMSubramanian Hariharan,
MD, FACP
Pfizer

Jose R. Perez, MD
Exelixis

Bradley McGregor, MD
Dana-Farber Cancer InstituteBringing it Back Together: Insights from Breakout
Group Discussions and Wrap-Up12:30 PM- 1:00 PMLunch and Poster Session
Zilker North Lobby and Zilker 1-21:00 PM- 2:30 PMView Poster ListingBreak1:00
PM- 1:15 PMA Combination Treatment for Patients with Advanced Renal Cell
Carcinoma
Supported by Exelixis
Hill Country Ballroom1:15 PM- 2:15 PMJohn Sarantopoulos, MD
UT Health San AntonioBreak2:15 PM- 2:30 PMSession 5: Keynote Lecture
Zilker 3-42:30 PM- 3:15 PMTian Zhang, MD, MHS
University of Texas Southwestern Medical CenterIntroduction2:30 PM- 2:35 PMTian
Zhang, MD, MHS
University of Texas Southwestern Medical CenterKeynote Lecture2:35 PM- 3:00
PMDavid F. McDermott, MD
Beth Israel Deaconess Question and Answer3:00 PM- 3:15 PMSession 6:
Multidisciplinary Team Approaches to Rare Subtypes
Zilker 3-43:15 PM- 4:30 PMJodi Maranchie, MD
University of Pittsburgh Medical CenterCollecting Duct, Sarcomatoid, and
Rhabdoid Subtypes3:15 PM- 3:27 PMDavid Braun, MD, PhD
Yale School of MedicineTranslocation Type Subtypes3:27 PM- 3:37 PMSrinivas R.
Viswanathan, MD, PhD
Dana-Farber Cancer InstituteRenal Medullary Cancer3:37 PM- 3:47 PMPavlos
Msaouel, MD, PhD
University of Texas MD Anderson Cancer CenterAbstract 1: Spatial molecular
imaging to profile the epithelial to
mesenchymal transition and immune crosstalk in sarcomatoid
renal cell carcinoma. 3:47 PM- 3:55 PMAllison May, MD
University of MichiganAbstract 2: Biomarkers of Disease Burden and Treatment
Response in Renal Medullary Carcinoma
*3rd Place Abstract Merit Award3:55 PM- 4:02 PMKyle A. Blum, MD, MS
University of Texas Houston, MD Anderson Cancer CenterBest Practices for
Multidisciplinary Care Teams Discussion and Panel Question and Answer4:03 PM-
4:30 PMPayal Kapur, MD
University of Texas Southwestern

Ivan Pedrosa, MD, PhD
University of Texas Southwestern

Steven Chang, MD, MS
Dana-Farber/ Brigham and Women’s Cancer Center

Stephanie Berg, DO
Loyola University

Chad Tang, MD
University of Texas MD Anderson Cancer CenterSession 7: Academy of Kidney Cancer
Investigators
Zilker 3-44:30 PM- 5:15 PMBrian Rini, MD
Vanderbilt University Medical CenterIntroduction4:30 PM- 4:40 PMBrian Rini, MD
Vanderbilt University Medical CenterCirculating Biomarkers in Renal Cell
Carcinoma4:40 PM- 4:55 PMWenxin Xu, MD
Dana-Farber Cancer InstituteRecurrent Genomic Alterations Driving Clear Cell
Renal Cell Carcinoma Development4:55 PM- 5:10 PMPeter Ly, PhD
University of Texas SouthwesternPanel Discussion and Question and Answer5:10 PM-
5:15 PMRemembering Nicholas J. Vogelzang5:15 PM- 5:30 PMNetworking Session:
Evening Reception and Poster Session
Zilker North Lobby and Zilker 1-25:30 PM- 6:45 PMView Poster ListingNetworking
Session: Poster Walks (In-person)
Poster Hall, Zilker North Lobby5:45 PM- 6:30 PMShawn Dason, MD
Ohio State University Medical Center

Sumanta “Monty” K. Pal, MD, FASCO
City of HopeNetworking Session: Poster Walks (Virtual)
Online via Zoom5:45 PM- 6:30 PMBradley McGregor, MD
Dana-Farber Cancer Institute

Phillip Pierorazio, MD
Penn Presbyterian Medical Center, Penn MedicineA Treatment Option for Certain
Patients With RCC in the Adjuvant Setting
Supported by Merck
Hill Country Ballroom6:00 PM- 7:00 PMAmit Mehta, MD
Premier Hematology Oncology

Saturday, November 5, 2022

SessionsTimeSpeakerEarly Morning Run (In-person only, Advance Registration
Required)
Hyatt Regency Hotel Lobby6:30 AM- 7:30 AMBradley McGregor, MD
Dana-Farber Cancer InstituteEarly Morning Yoga (In-person only, Advance
Registration Required)
Big Bend Ballroom A/B6:30 AM- 7:30 AMPhillip Pierorazio, MD
Penn Presbyterian Medical Center, Penn MedicineRegistration Open6:30 AM- 2:00
PMPoster and Exhibit Hall Open6:30 AM- 2:00 PMView Poster ListingDay 2 Welcome
and Updates from the Kidney Cancer Association
Zilker 3-48:00 AM- 8:15 AMKidney Cancer Association Initiatives, Progress, and
New Horizons8:00 AM- 8:15 AMDaniel J. George, MD
Duke UniversitySession 8: Regulatory for New Trials
Zilker 3-48:15 AM- 9:15 AMSumanta “Monty” K. Pal, MD, FASCO
City of HopeThe New Era of Clinical Trials: Meeting Regulatory Requirements and
Decreasing Barriers8:17 AM- 8:30 AMElaine Chang, MD
US Food and Drug AdministrationChoosing Endpoints and Designs of Future Trials:
OS vs PFS and Comparator Cohorts8:30 AM- 8:43 AMChung-Han “Joe” Lee, MD, PhD, BS
Memorial Sloan Kettering Cancer Center Experiences With Patient Acceptance of
Clinical Trials8:43 AM- 8:56 AMLaura S. Wood, RN, MSN, OCN, Ret.
Cleveland Clinic Taussig Cancer CenterAbstract 3: Critical assessment of
eligibility criteria in contemporary renal cell carcinoma (RCC) trials
evaluating systemic therapy8:56 AM- 9:03 AMDaniela V. Castro, MS
City of Hope Comprehensive Cancer CenterPanel Discussion and Question and
Answer9:04 AM- 9:15 AMSession 9: Oral Abstract Session
Zilker 3-49:15 AM- 10:00 AMYousef Zakharia, MD
University of IowaAbstract 5: CD200-mediated immune evasion in clear cell renal
cell carcinoma
*1st Place Abstract Merit Award 9:16 AM- 9:23 AMGemma E. Davies, BSc, MSc
Cardiff UniversityAbstract 6: Clinical outcomes with nivolumab/ipilimumab
(nivo/ipi) with or without CBM588 in metastatic renal cell carcinoma (mRCC):
Long-term follow-up of a randomized phase Ib clinical trial
*2nd Place Abstract Merit Award 9:24 AM- 9:31 AMNazli Dizman, MD
Yale New Haven HospitalAbstract 7: Assessment of Clavien-Dindo Classification in
patients with Metastatic Clear Cell Renal Cell Carcinoma (mccRCC) who received
Perioperative Cabozantinib and Nivolumab on Cyto-KIK Clinical Trial9:32 AM- 9:39
AMKarie Runcie, MD
New York Presbyterian Hosital, Columbia University Abstract 8: Genetic Ancestry
and Molecular Correlations in Patients with Kidney Cancers9:40 AM- 9:47 AMRitesh
Kotecha, MD
Memorial Sloan Kettering Cancer CenterPanel Discussion and Question and
Answer9:48 AM- 10:00 AMBreak10:00 AM- 10:15 AMSession 10: Genetics in Kidney
Cancer Demonstrated Through Case-Based Presentations
Zilker 3-410:15 AM- 11:45 AMMaria Carlo, MD
Memorial Sloan Kettering Cancer CenterWho, What, When, Where, and Why of
Genetics in Kidney Cancer: Considerations for the Genetics Consensus
Statement10:15 AM- 10:35 AMMaria Carlo, MD
Memorial Sloan Kettering Cancer CenterSomatic Testing Considerations10:35 AM-
10:55 AMElizabeth “Lisa” Henske, MD
Brigham and Women’s HospitalGenetics in the Scope of BHD, TSC-associated RCC,
HLRCC, FH deficient RCC, and VHL10:55 AM- 11:15 AMRamprasad “Ram” Srinivasan,
MD, PhD
National Cancer Institute at the National Institutes of HealthAbstract 4:
Delineating Clinical and Radiologic Features of Rare Kidney Cancer Genetic
Syndromes11:15 AM- 11:22 AMPamela I. Causa Andrieu, MD
Memorial Sloan Kettering Cancer CenterPanel Discussion and Question and
Answer11:23 AM- 11:45 AMSession 11: Risk Stratification: The Evolving State of
RCC
Zilker 3-411:45 AM- 12:30 PMKaty Beckermann, MD, PhD
Vanderbilt University Medical CenterUsing Proper Risk Stratification and How to
do it Accurately11:45 AM- 12:00 PMDaniel Heng, MD, MPH, FRCPC
Tom Baker Cancer CentreWhat’s Wrong with the Guidelines and How Do We Move
Forward?12:00 PM- 12:15 PMA. Ari Hakimi, MD
Memorial Sloan Kettering Cancer CenterPanel Discussion and Question and
Answer12:15 PM- 12:30 PMBreak and Lunch Available
Zilker North Lobby and Zilker 1-212:30 PM- 1:30 PMSession 12: Kidney Cancer
Association Awards Recognition Ceremony
Zilker 3-412:45 PM- 1:25 PMBradley C. Leibovich, MD
Mayo Clinic

Brian Rini, MD
Vanderbilt-Ingram Cancer CenterPresentation of the Eugene P. Schonfeld Award
12:45 PM- 12:55 PMDavid F. McDermott, MD
Beth Israel Deaconess Presentation of the Christopher G. Wood Rising Star
Award12:55 PM- 1:05 PMDaniel Shapiro, MD
University of Wisconsin-MadisonPresentation of the Kidney Cancer Association
Nicholas J. Vogelzang Humanitarian Award1:05 PM- 1:25 PMNicholas J. Vogelzang,
MD, FASCO, FACP
Comprehensive Cancer Centers of NevadaSession 13: WoodFire®
WoodFire® is an exciting chance to watch clinicians debate the various treatment
options for each presented oncology case. It’s the fiercest tumor board you’ll
ever see!
Zilker 3-41:25 PM- 2:25 PMCase Presentation and Discussion 11:25 PM- 1:40
PMDaniel Shapiro, MD
University of Wisconsin-MadisonCase Presentation and Discussion 21:40 PM- 1:55
PMVignesh Packiam, MD
University of IowaCase Presentation and Discussion 31:55 PM- 2:10 PMWalter
Stadler, MD
University of Chicago Comprehensive Cancer CenterCase Presentation and
Discussion 42:10 PM- 2:25 PMRana McKay, MD
University of California, San DiegoMeeting Adjourn
Zilker 3-42:25 PM- 2:40 PMEric A. Singer, MD, MA, MS, FACS, FASCO
Ohio State Wexner Medical Center





© 2022 Kidney Cancer Association. All Rights Reserved. Privacy Policy |
WordPress website by Gecko Designs

 * Facebook
 * Instagram
 * YouTube
 * LinkedIn
 * Twitter